vimarsana.com

Latest Breaking News On - Hong kong listed huatai securities - Page 1 : vimarsana.com

China Digest: Lynk Pharma, Bestzyme Bioengineering bag funds

Biopharmaceutical firm Lynk Pharmaceuticals has bagged 200 million yuan ($28.2 million) in its Series C1 round, according to a release.

Hong kongHong kong stock exchange onChina lynk pharmaceuticalsDaoxing entrepreneurship investment management centerLynk pharmaceuticalsLiandong investment groupBestzyme bioengineeringChina grand prosperity investmentHangzhou based tailong venture capitalLiandou valleyLilly asiaHong kong listed genscript biotechHong kong stock exchangeGenscript biotechHuatai zijin investmentHong kong listed huatai securities

China Digest: New Vision, Coherent Biopharma snap funding

Shunwei Capital-backed New Vision has raised $28.7 million in a Series D round, while Coherent Biopharma has secured $100 million in Series B and B+ rounds.

Hefei industry investment holdingInternational holdingsAgricultural bankJiangsu hengrui pharmaceuticalsShanghai alliance investmentShunwei capital backed new visionHuatai zijin investmentXunfei capitalCoherent biopharmaHong kong listed huatai securitiesChangjiang capitalLongding capitalXinding capitalHoldings limitedChina limitedSuzhou harvest capital

vimarsana © 2020. All Rights Reserved.